pharmaphorum5d
Biogen’s Skyclarys is first EU drug for Friedreich’s ataxia
After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.
Frontiers4d
Neurocognitive and cerebellar function in ADHD, autism and spinocerebellar ataxia
Several neuropsychiatric disorders such as attention deficit-hyperactivity disorder (ADHD), autism spectrum disorder (ASD), as well as neurological diseases such as spinocerebellar ataxia type 3 (SCA3 ...
Frontiers4d
Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration
So far, few antibodies have been confirmed to be directly neurotoxic. The most striking evidence is provided by tumor-associated autoantibodies causing paraneoplastic neurological disorders. These ...
BMJ4d
Gluten sensitivity as a neurological illness
Department of Neurology, The Royal Hallamshire Hospital, Glossop Road, Sheffield, S10 2JF, UK Correspondence to: Dr M Hadjivassiliou, Department of Neurology, The ...